REVIEW

In stent restenosis: bane of the stent era

A K Mitra and D K Agrawal

Departments of Biomedical Sciences, Medicine, and Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, NE 68178, NE, USA

Correspondence to:
Correspondence to:
Professor D K Agrawal
Professor of Biomedical Sciences, Medicine, and Medical Microbiology and Immunology, CRISS II Room 510, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA; dkagr{at}creighton.edu

The long term outcome of stent implantation is affected by a process called in stent restenosis (ISR). Multiple contributory factors have been identified, but clear understanding of the overall underlying mechanism remains an enigma. ISR progresses through several different phases and involves numerous cellular and molecular constituents. Platelets and macrophages play a central role via vascular smooth muscle cell migration and proliferation in the intima to produce neointimal hyperplasia, which is pathognomic of ISR. Increased extracellular matrix formation appears to form the bulk of the neointimal hyperplasia tissue. Emerging evidence of the role of inflammatory cytokines and suppressors of cytokine signalling make this an exciting and novel field of antirestenosis research. Activation of Akt pathway triggered by mechanical stretch may also be a contributory factor to ISR formation. Prevention of ISR appears to be a multipronged attack as no therapeutic "magic bullet" exists to block all the processes in one go.

Abbreviations: EC, endothelial cell; ECM, extracellular matrix; ER, endoplasmic reticulum; IAP, inhibitor of apoptosis protein; IGF, insulin-like growth factor; ISR, in stent restenosis; MAPK, mitogen activated protein kinase; MCP, monocyte chemoattractant protein; NIH, neo-intimal hyperplasia; PCNA, proliferating cell nuclear antigen; PTCA, percutaneous transluminal coronary angioplasty; SMC, smooth muscle cell; SOCS, suppressors of cytokine signalling; TNF, tumour necrosis factor; TNF-R, TNF receptor; TUNEL, TdT/dUTP biotin nick end labelling; VEGF, vascular endothelial growth factor; VSMC, vascular smooth muscle cell

Keywords: apoptosis; atherosclerosis; IGF-1; intimal hyperplasia; intravascular stenting; restenosis; suppressors of cytokine signalling; vascular smooth muscle cells

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Lee, C.-S., Kwon, Y.-W., Yang, H.-M., Kim, S.-H., Kim, T.-Y., Hur, J., Park, K.-W., Cho, H.-J., Kang, H.-J., Park, Y.-B., Kim, H.-S. (2009). New Mechanism of Rosiglitazone to Reduce Neointimal Hyperplasia: Activation of Glycogen Synthase Kinase-3{beta} Followed by Inhibition of MMP-9. Arterioscler. Thromb. Vasc. Bio. 29: 472-479 [Abstract] [Full Text]  
• Amer, M. S, Li, J., O'Regan, D. J., Steele, D. S., Porter, K. E., Sivaprasadarao, A., Beech, D. J. (2009). Translocon closure to Ca2+ leak in proliferating vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 296: H910-H916 [Abstract] [Full Text]  
• Aukrust, P., Halvorsen, B., Yndestad, A., Ueland, T., Oie, E., Otterdal, K., Gullestad, L., Damas, J. K. (2008). Chemokines and Cardiovascular Risk. Arterioscler. Thromb. Vasc. Bio. 28: 1909-1919 [Abstract] [Full Text]  
• Schultz, K., Murthy, V., Tatro, J. B., Beasley, D. (2007). Endogenous interleukin-1{alpha} promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 292: H2927-H2934 [Abstract] [Full Text]  
• Khan, R., Agrotis, A., Bobik, A. (2007). Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury. Cardiovasc Res 74: 223-234 [Abstract] [Full Text]  
• Ashley, E. A., Ferrara, R., King, J. Y., Vailaya, A., Kuchinsky, A., He, X., Byers, B., Gerckens, U., Oblin, S., Tsalenko, A., Soito, A., Spin, J. M., Tabibiazar, R., Connolly, A. J., Simpson, J. B., Grube, E., Quertermous, T. (2006). Network Analysis of Human In-Stent Restenosis. Circulation 114: 2644-2654 [Abstract] [Full Text]